Patients Experience 100 Percent Remission in Clinical Trial
A small clinical trial reported that 100 percent of the patients experienced remission of rectal cancer after immunotherapy.
By May 31, 2022, most health insurance plans will fully cover this procedure to evaluate a positive stool-based test for colon cancer. Check with your insurance about your coverage.Learn More
The gastroenterologists and staff at MidAtlantic Endoscopy are dedicated to providing quality, affordable care to the greater Lancaster community in our quest to lower colon cancer rates and treat an array of digestive diseases, including Crohn’s Disease, irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD).
MidAtlantic Endoscopy is skilled in performing a myriad of digestive procedures, including colonoscopy, esophageal dilation, flexible sigmoidoscopy, upper endoscopy and small bowel enteroscopy.
With two convenient locations in Lancaster and Ephrata, we proudly serve the Lancaster, York and Hershey areas. Our new, state-of-the-art facility in Lancaster offers all the technology of a hospital in a comfortable, relaxed environment. The new center replaces two centers located within the Penn Medicine Lancaster General Health Suburban Out-Patient Pavilion with one convenient location, offering the same high quality of patient care in a new updated environment. We also have an Ephrata location at 4140 Oregon Pike.
A small clinical trial reported that 100 percent of the patients experienced remission of rectal cancer after immunotherapy.Read More
People who are overweight or obese may skip life-saving cancer screenings because they fear their doctor’s judgment.Read More
A new meta-analysis from Johns Hopkins School of Medicine suggests taller people may be more likely to develop colon cancer than shorter people.Read More